-
Research
-
Grantee & Partner News
In the Spotlight
Early Results from DETECT Study Suggest Fitness Trackers and Smartwatches Can Predict COVID-19 Infection
The Scripps Research Institute ∙ 10/29/2020 ∙ CTSA Program
Examining data from the first six weeks of their landmark DETECT study, a team of NCATS-supported scientists from the Scripps Research Translational Institute sees encouraging signs that wearable fitness devices can improve public health efforts to control COVID-19.
The DETECT study, launched on March 25, uses a mobile app to collect smartwatch and activity tracker data from consenting participants, and also gathers their self-reported symptoms and diagnostic test results.
November 2020
-
Mayo Clinic Launches COVID-19 Research Vaccine Registry to Identify People Interested in Participating in Future Clinical Trials
Mayo Clinic ∙ 11/23/2020 ∙ CTSA Program -
Outstanding Results from Phase 3 COVID-19 Vaccine Trial Led by Former Georgia CTSA KL2 Scholar
Georgia Clinical & Translational Science Alliance ∙ 11/20/2020 ∙ CTSA Program -
Memories Create ‘Fingerprints’ That Reveal How the Brain is Organized
University of Rochester Medical Center ∙ 11/20/2020 ∙ CTSA Program -
Amnion Foundation Seed Grant Recipients
Amnion Foundation ∙ 11/20/2020 ∙ 3-D Modeling -
Georgia CTSA Leader Heads NIH’s Georgia CEAL to Address COVID-19 Disparities
Georgia Clinical & Translational Science Alliance ∙ 11/20/2020 ∙ CTSA Program -
Researchers Developing Drugs to Help Prevent Preterm Birth
Texas A&M University ∙ 11/19/2020 ∙ Tissue Chip -
Young People with Disabilities Focus of COVID-19 Testing Grant
Washington University in St. Louis ∙ 11/19/2020 ∙ CTSA Program -
Study Reveals How Smoking Worsens COVID-19 Infection in the Airways
University of California, Los Angeles ∙ 11/17/2020 ∙ CTSA Program -
ReveraGen Receives $3.3 Million NIH Commercialization Readiness Pilot Grant for NDA Preparations for Vamorolone in Duchenne Muscular Dystrophy
ReveraGen BioPharma, Inc. ∙ 11/17/2020 ∙ SBIR/STIR -
Study Explores Sleep Apnea, Autoimmune Disease Link
University of Georgia ∙ 11/17/2020 ∙ CTSA Program -
International Digital Nephropathology Repositories Set Stage for Artificial Intelligence Applications in Study of Rare Kidney Diseases
Rare Diseases Clinical Research Network ∙ 11/17/2020 ∙ RDCRN -
Curiel Receives NIH Grant to Research Use of Viruses to Deliver CRISPR Machinery in Locations in Body
Washington University School of Medicine in St. Louis ∙ 11/17/2020 ∙ Somatic Cell Genome Editing -
Health Care Workers Most at Risk for COVID-19: A Rutgers Study Finds Nurses Have the Highest Prevalence of Infection
Rutgers, The State University of New Jersey ∙ 11/16/2020 ∙ NCATS -
Study: Respiratory Failure in COVID-19 Usually Not Driven by Cytokine Storm
Washington University School of Medicine in St. Louis ∙ 11/13/2020 ∙ CTSA Program -
The i2b2 tranSMART Foundation Announces COVID Authors and COVID Datathon
i2b2 tranSMART Foundation ∙ 11/13/2020 ∙ CTSA Program -
Fluvoxamine May Prevent Serious Illness in COVID-19 Patients
Washington University School of Medicine in St. Louis ∙ 11/12/2020 ∙ CTSA Program -
CODA Biotherapeutics Receives Grant from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH)
CODA Biotherapeutics, Inc. ∙ 11/10/2020 ∙ HEAL -
UAMS to Test Telehealth to Improve Death Rate Among Rural Pregnant Women
University of Arkansas for Medical Sciences ∙ 11/10/2020 ∙ CTSA Program -
A Perspective on the Current State of Clinical Research Education and Training
The Association of Clinical Research Professionals ∙ 11/10/2020 ∙ CTSA Program -
Regenstrief, Indiana CTSI, Datavant Partner on NIH National COVID-19 Data Effort
Regenstrief Institute ∙ 11/09/2020 ∙ CTSA Program -
Serious Disparities in Care and Outcomes Found among Black and Non-White Heart Patients
American Heart Association, Inc. ∙ 11/09/2020 ∙ NCATS -
‘Organ on a Chip’ Is the Wave of the Future
University of Rochester ∙ 11/09/2020 ∙ Tissue Chip -
Liver Scarring Relatively Common Among Middle-Aged Adults
Boston University School of Medicine ∙ 11/09/2020 ∙ CTSA Program -
Finding Treatments for Muscular Dystrophy Starts with Understanding the Condition Better
Virginia Commonwealth University ∙ 11/09/2020 ∙ NCATS -
Medicaid Expansion Linked to Lower Mortality Rates for Three Major Types of Cancer
Dana-Farber Cancer Institute ∙ 11/05/2020 ∙ CTSA Program -
Speeding COVID-19 Drug Discovery with Quantum Dots
NIH Director’s Blog ∙ 11/05/2020 ∙ TRND -
UAMS Diabetes Study Gets $400,000 to Meet COVID-19 Restrictions
University of Arkansas for Medical Sciences ∙ 11/04/2020 ∙ CTSA Program -
Coronavirus Infection Odds Twice as High Among Black, Latinx Hospital Workers
Rutgers, The State University of New Jersey ∙ 11/04/2020 ∙ NCATS -
UC Physician Suggests Screening Teens Who Visit Emergency Rooms for Sexually Transmitted Infections
University of Cincinnati ∙ 11/04/2020 ∙ CTSA Program -
New Discoveries About Glucose Metabolism Could Improve Diabetes Treatment
Yale School of Medicine ∙ 11/03/2020 ∙ Chemistry Technology -
Cornea Appears to Resist Infection from Novel Coronavirus
Washington University School of Medicine in St. Louis ∙ 11/03/2020 ∙ CTSA Program -
Hillstream BioPharma Announces Renewal of CRADA with National Center for Advancing Translational Sciences for Use of Quatramer™ Technology with HDAC6-PI3Kδ Dual Inhibitor for AML
Hillstream BioPharma ∙ 11/02/2020 ∙ NCATS -
NIAID, NCI, NCATS, NIEHS: Experimental Treatment for Children with Eczema
The NIH Catalyst ∙ 11/01/2020 ∙ NCATS
October 2020
-
CCTS Grant Will Provide Support to Scientists to Move Their Discoveries to Market
The University of Alabama at Birmingham ∙ 10/30/2020 ∙ CTSA Program, SBIR/STIR -
Roswell Park Sees Suggestion of Benefit in First Clinical Trial to Combine Beta-Blocker and Checkpoint Inhibitor
Roswell Park Comprehensive Cancer Center ∙ 10/30/2020 ∙ CTSA Program -
Informatics Approach Helps Reveal Risk Factors for Pressure Injuries
American Association of Critical-Care Nurses ∙ 10/30/2020 ∙ NCATS -
Early Results from DETECT Study Suggest Fitness Trackers and Smartwatches Can Predict COVID-19 Infection
The Scripps Research Institute ∙ 10/29/2020 ∙ CTSA Program -
Aspirin Use Best for Those with High Coronary Calcium, Low Risk of Bleeding
The University of Texas Southwestern Medical Center ∙ 10/28/2020 ∙ CTSA Program -
NORD Announces RareLaunch Workshops to Support Those Seeking to Start Rare Disease Nonprofits or Research Programs
National Organization for Rare Disorders ∙ 10/28/2020 ∙ Rare Diseases -
Early UAMS Study Results Show 3.5% of Arkansans Infected by Coronavirus
University of Arkansas for Medical Sciences ∙ 10/23/2020 ∙ CTSA Program -
Virtual 2020 Pilot Studies Colloquium Showcased Broad Range of Innovative Research
University at Buffalo, Clinical and Translational Science Institute ∙ 10/21/2020 ∙ CTSA Program -
Sponsored Research at VCU Hits New All-Time High of $335M
Virginia Commonwealth University ∙ 10/21/2020 ∙ CTSA Program -
Neuron-Based Gene Expression Study Reveals Insights on Fear and Its Regulation
McLean Hospital ∙ 10/20/2020 ∙ CTSA Program -
PerkinElmer Immunoassay Helps NIH NCATS Team Identify Therapeutic Compounds Capable of Disrupting the SARS-CoV-2 Spike Protein/ACE2 Interaction
PerkinElmer, Inc. ∙ 10/20/2020 ∙ New Therapeutic Uses -
U.S. Government Invests in Non-Animal “Tissue Chips”
National Anti-Vivisection Society ∙ 10/19/2020 ∙ Tissue Chip -
TRI to Support the ACTIV-1 IM Study for Treating COVID-19
Technical Resources International, Inc. ∙ 10/19/2020 ∙ NCATS -
MMCRI Joins National COVID Data Research Collaborative
MaineHealth ∙ 10/19/2020 ∙ CTSA Program -
Immune Modulator Drugs for COVID-19 Focus of Major NIH Clinical Trial
Washington University School of Medicine in St. Louis ∙ 10/16/2020 ∙ CTSA Program -
‘Kidney on a Chip’ Research Receives Multi-Million-Dollar Funding for Drug Testing
THE DAILY of the University of Washington ∙ 10/15/2020 ∙ Tissue Chip -
Explore & More Launches “Sofia Learns About Research” in Partnership with UB
University at Buffalo ∙ 10/15/2020 ∙ CTSA Program -
Rutgers Awarded $5 Million NIH Grant to Improve Access to COVID-19 Testing
Rutgers, The State University of New Jersey ∙ 10/15/2020 ∙ CTSA Program -
Insomnia Symptoms in the Transition from Childhood to Adolescence
L&D Associates ∙ 10/15/2020 ∙ NCATS -
Inhibition of HDAC and mTOR May Improve Outcomes for Relapsed/Refractory Hodgkin Lymphoma
American Association for Cancer Research ∙ 10/14/2020 ∙ NCATS -
Reviving Cells after a Heart Attack: Researchers Unravel the Healing Mechanisms of Extracellular Vesicles and Demonstrate Their Healing Power on a Heart-on-a-Chip
Harvard, John A. Paulson School of Engineering and Applied Sciences ∙ 10/14/2020 ∙ Tissue Chip -
Combined Inhibition of HDAC and mTOR May Improve Outcomes in Patients with Relapsed/Refractory Hodgkin Lymphoma
American Association for Cancer Research ∙ 10/14/2020 ∙ CTSA Program -
NIH Funds $2.5 Million UAMS Study of Healthy-Food Delivery to Combat Diabetes in Rural Arkansas
University of Arkansas for Medical Sciences ∙ 10/13/2020 ∙ CTSA Program -
Fiocruz and Eatris Sign Partnership for Translational Science
Fiocruz ∙ 10/13/2020 ∙ NCATS -
UR CTSI Broadens Patient Cohort Discovery Capability at UR Through ACT Network
University of Rochester Medical Center, Clinical & Translational Science Institute ∙ 10/07/2020 ∙ CTSA Program -
Dystonia Coalition Database Uncovers Characteristics of Upper Limb Dystonia
Rare Diseases Clinical Research Network ∙ 10/06/2020 ∙ RDCRN -
Machine Learning Detects Early Signs of Osteoarthritis
NIH Research Matters ∙ 10/06/2020 ∙ NCATS -
UCLA to Lead Statewide Coalition to Address COVID-19’s Impact on Communities at Risk
University of California, Los Angeles ∙ 10/05/2020 ∙ CTSA Program -
Basis of Developmental Disabilities Focus of $11.3 Million in Grants
Washington University School of Medicine in St. Louis ∙ 10/02/2020 ∙ NCATS -
Kidney-Chip Research Is Funded for Prime-Time Opportunity
UW Medicine ∙ 10/02/2020 ∙ Tissue Chip
September 2020
-
Celebrating Successes and Next Steps for the Science of Behavior Change Program
NCATS, NIA ∙ 09/30/2020 ∙ NIH -
Trans-NIH
IMPROVE Initiative ∙ 09/29/2020 ∙ NIH -
Women Received Less Aggressive Care than Men after a Heart Attack with Pumping Failure
American Heart Association, Inc. ∙ 09/29/2020 ∙ NCATS -
More ‘Omics for SARS-CoV-2, Insights into the Spike Protein, Crowdsourcing Questions: COVID-19 Updates
Bio•IT World ∙ 09/25/2020 ∙ TRND -
Antibodies Protect Against Wide Range of Influenza B Virus Strains
Washington University School of Medicine in St. Louis ∙ 09/24/2020 ∙ CTSA Program -
Kemp Proteins Selected to Provide Assay Development for Potential First-In-Class Therapy for Chronic Spinal Cord Injury
Kemp Proteins ∙ 09/22/2020 ∙ BrIDGs -
DTx Pharma Receives New Funding Grant to Advance RNA-based Therapeutic Programs for Charcot-Marie Tooth (CMT)
DTx Pharma ∙ 09/22/2020 ∙ Rare Diseases -
Study Reveals Racial Disparities in Clinical Trial Recruitment and Points to Strategies to Achieve More Inclusive Clinical Research
Beth Israel Deaconess Medical Center ∙ 09/21/2020 ∙ CTSA Program -
COVID-19 Clinical Data Available for Research through New N3C Analytics Platform
Oregon Health & Science University ∙ 09/18/2020 ∙ CTSA Program -
HSS Researchers Launch Study Using Novel MRI Techniques to Find a Biomarker for Parsonage-Turner Syndrome, A Painful Nerve Disorder
Hospital for Special Surgery ∙ 09/18/2020 ∙ NCATS -
NRL, NCATS Scientists Develop Method to Safely Study COVID-19, Other Contagious Diseases
U.S. Naval Research Lab ∙ 09/17/2020 ∙ NCATS -
Trial Aims to Determine if Melatonin Can Treat COVID-19
University at Buffalo ∙ 09/16/2020 ∙ CTSA Program -
Graduate Student Spotlight: Investigating a Cancer Linked to a Rare Genetic Disorder
Van Andel Institute ∙ 09/16/2020 ∙ Rare Diseases -
National Institutes of Health, Hispanic and Latinos, Supporting the Fight Against COVID-19
National Institutes of Health, Office of Equity, Diversity, and Inclusion ∙ 09/15/2020 ∙ NCATS -
Can Melatonin Treat COVID-19? A UB Pioneer in Melatonin Research and Colleagues Launch a Clinical Trial to Find Out
University at Buffalo ∙ 09/14/2020 ∙ CTSA Program -
Santhera Announces Publication on Molecular Distinctions of Vamorolone Compared to Corticosteroids
Santhera Pharmaceuticals ∙ 09/14/2020 ∙ NCATS -
Mass General Nurses Willing to Counsel Patients on Gun Safety Protocols after Receiving Hospital-led Education, Study Finds
Massachusetts General Hospital ∙ 09/11/2020 ∙ CTSA Program -
Santhera Announces Full Enrollment of ReveraGen’s Pivotal VISION-DMD Study with Vamorolone in Duchenne Muscular Dystrophy
Santhera Pharmaceuticals ∙ 09/11/2020 ∙ NCATS -
VIR-CLASP Reveals New Insights into Cellular Mechanisms of Viral Immune Response
Vanderbilt University School of Medicine ∙ 09/10/2020 ∙ CTSA Program -
Seven in 10 Americans Willing to Get COVID-19 Vaccine, Survey Finds
The Ohio State University ∙ 09/10/2020 ∙ CTSA Program -
Deep Look at Immune Cells in Patients’ Tumors Reveals Insights on Timing for Treatment Combinations
Roswell Park Comprehensive Cancer Center ∙ 09/08/2020 ∙ CTSA Program -
Helping Teens with Type 1 Diabetes Improve Diabetes Control with MyDiaText
University of Pennsylvania School of Nursing ∙ 09/03/2020 ∙ CTSA Program -
New Computational Tool Allows Researchers to Predict Key Functional Sites in Proteins
Penn State College of Medicine ∙ 09/03/2020 ∙ CTSA Program -
COVID-19 Posing Grim Challenge for Sickle Cell Disease Patients
NCATS, NHLBI ∙ 09/03/2020 ∙ CTSA Program -
Santhera Exercises Option to Obtain Worldwide Rights to Vamorolone in Duchenne Muscular Dystrophy and All Other Indications
Santhera Pharmaceuticals ∙ 09/02/2020 ∙ NCATS -
Asking the Right Questions
North Carolina Translational and Clinical Sciences Institute ∙ 09/01/2020 ∙ CTSA Program -
Study Ties COVID-19-Related Syndrome in Kids to Altered Immune System
NIH Director’s Blog ∙ 09/01/2020 ∙ GARD -
Faculty, Residents, Students, Staff Get Awards of Excellence
UBMD Physicians’ Group ∙ 09/01/2020 ∙ CTSA Program -
Researching the Impact of COVID-19 on Families with Autism
North Carolina Translational and Clinical Sciences Institute ∙ 09/01/2020 ∙ CTSA Program
August 2020
-
Clinical Features, Diagnostics, and Outcomes of Patients Presenting with Acute Respiratory Illness: A Retrospective Cohort Study of Patients with and without COVID-19
Washington University School of Medicine in St. Louis, Hospital Medicine Virtual Journal Club ∙ 08/31/2020 ∙ NCATS -
Virpax Enters into an NIH Collaboration to Further Develop NES100 for Acute and Chronic Non-Cancer Pain
VIRPAX Pharmaceuticals ∙ 08/31/2020 ∙ NCATS -
UAMS Researchers See 43 Percent Funding Increase
University of Arkansas for Medical Sciences ∙ 08/28/2020 ∙ CTSA Program -
NIH Grant Will Allow UC Davis Health to Train Community Health Workers in COVID-19 Contact Tracing
UC Davis Health ∙ 08/28/2020 ∙ CTSA Program -
Researchers Receive New Grant to Improve Research in Underserved Communities
University of Florida, College of Public Health & Health Professions ∙ 08/27/2020 ∙ CTSA Program -
Genetic Causes of Severe Childhood Brain Disorders Found Using New Computational Methods
Children’s Hospital of Philadelphia ∙ 08/26/2020 ∙ CTSA Program -
To Improve Research in Underserved Communities, Train Community Health Workers
Michigan Medicine, University of Michigan ∙ 08/26/2020 ∙ CTSA Program -
Miller School Part of Nationwide Convalescent Plasma Study
University of Miami, Leonard M. Miller School of Medicine ∙ 08/26/2020 ∙ CTSA Program -
Female Chromosomes Offer Resilience to Alzheimer’s
University of California, San Francisco ∙ 08/26/2020 ∙ CTSA Program -
Study Shows Promise for Two-Day Therapy to Treat PTSD, Improve Relationships
Penn State ∙ 08/24/2020 ∙ CTSA Program -
Expanded Access Program for Convalescent Plasma Discontinues Enrollment as FDA Authorizes Its Emergency Use
Mayo Clinic ∙ 08/23/2020 ∙ CTSA Program -
VUMC Awarded $34 Million to Lead Nationwide Convalescent Plasma Study
Vanderbilt University Medical Center ∙ 08/21/2020 ∙ CTSA Program -
Randomized Controlled Trial to Test if Convalescent Plasma Can Treat COVID-19 Disease
University of Miami, Miller School of Medicine ∙ 08/21/2020 ∙ CTSA Program -
UMass Medical School Granted Five-Year, $30 Million Clinical and Translational Sciences Award
University of Massachusetts Medical School ∙ 08/21/2020 ∙ CTSA Program -
Trefoil Therapeutics Begins First Clinical Trial of Regenerative Treatment for Patients with Corneal Endothelial Dystrophies
Trefoil Therapeutics ∙ 08/19/2020 ∙ NCATS -
Team Is First in Texas to Join NIH-Sponsored Study Investigating Efficacy of Convalescent Plasma for COVID-19
The University of Texas Health Science Center at Houston ∙ 08/18/2020 ∙ CTSA Program -
Scan for Arterial Plaque Is Better at Predicting Heart Attack than Stroke
The University of Texas Southwestern Medical Center ∙ 08/18/2020 ∙ NCATS -
Multifocal Contact Lenses Slow Myopia Progression in Children
NIH Research Matters ∙ 08/18/2020 ∙ NCATS -
New KL2 Career Development Awardees Investigate Lung Disease, Frailty in Colon Cancer Survivors
University of Rochester Clinical & Translational Science Institute ∙ 08/17/2020 ∙ CTSA Program -
Gene Variants Help Explain Connection Between Skin Disorder and Food Allergy Risk
Cincinnati Children's Hospital Medical Center ∙ 08/14/2020 ∙ CTSA Program -
Stakeholders Call for Regulatory Clarity in Rare Disease Research Network
Regulatory Affairs Professionals Society ∙ 08/13/2020 ∙ CTSA Program, RDCRN -
Study Focuses on a Different Kind of Liquid Biopsy to Detect Cancer
Memorial Sloan Kettering Cancer Center ∙ 08/13/2020 ∙ CTSA Program -
Corning and BioSurfaces Enter into Supply Agreement to Support 3D Tissue Fabrication
BioSurfaces, Inc ∙ 08/12/2020 ∙ 3-D Modeling -
Study Points Out Opioid Risks for Hospital Patients Transitioning to Skilled Nursing Facilities
Oregon State University ∙ 08/11/2020 ∙ CTSA Program -
New Approach to Treating Osteoarthritis Advances
NYU Langone Health ∙ 08/10/2020 ∙ CTSA Program -
The Urgency of Diversity
The Association of Clinical Research Professionals ∙ 08/10/2020 ∙ NCATS -
Targeting Ultrasound for Noninvasive Diagnosis of Brain Cancer
Washington University in St. Louis ∙ 08/10/2020 ∙ CTSA Program -
Exploring Drug Repurposing for COVID-19 Treatment
NIH Director’s Blog ∙ 08/04/2020 ∙ NCATS -
Keros Therapeutics, Inc. Announces Completion of Dosing of Planned Cohorts in KER-047 Phase 1 Trial and Provides Program Update
Keros Therapeutics, Inc. ∙ 08/04/2020 ∙ NCATS -
Dartmouth Engineers Team Up on NIH-Funded Program for Artificial Intelligence Tool to Help Doctors Cure Disease
Thayer School of Engineering at Dartmouth ∙ 08/04/2020 ∙ Biomedical Data Translator, CTSA Program -
COVID-19 Connections
Harvard Medical School ∙ 08/03/2020 ∙ CTSA Program -
Penn Researchers Identify New Genetic Cause of a Form of Inherited Neuropathy
Penn Medicine ∙ 08/03/2020 ∙ RDCRN
July 2020
-
Senate Committee Proposes $15.5 Billion in COVID-19 Relief for NIH
Research!America ∙ 07/31/2020 ∙ NCATS -
Kebotix Expands With Second Research Lab: Tech Startup Meeting Demand for its Materials Discovery Platform Capabilities
Kebotix, Inc. ∙ 07/30/2020 ∙ NCATS -
Johns Hopkins Receives $35 Million in Funding from Department of Defense for COVID-19 Blood Plasma Trials
Johns Hopkins Bloomberg School of Public Health ∙ 07/30/2020 ∙ CTSA Program -
Older Americans Receive Cancer Screenings Past Recommended Age
Penn State ∙ 07/29/2020 ∙ CTSA Program -
Senate Releases New Coronavirus Relief Package
American Association for Dental Research ∙ 07/29/2020 ∙ NCATS -
Images of Antibodies as They Neutralize the COVID-19 Virus
California Institute of Technology ∙ 07/29/2020 ∙ NCATS -
Wisconsin Farm Related Fatalities Report Issued
University of Wisconsin-Madison ∙ 07/28/2020 ∙ CTSA Program -
Research Brief: New Study Explores How Coronavirus Travels Indoors
University of Minnesota ∙ 07/28/2020 ∙ CTSA Program -
Researchers Find End-of-Life Practices Vary Widely by Region
Beth Israel Deaconess Medical Center ∙ 07/24/2020 ∙ CTSA Program -
Lego-inspired Bone and Soft Tissue Repair with Tiny, 3D-Printed Bricks
Oregon Health & Science University ∙ 07/24/2020 ∙ CTSA Program -
Phage Therapy Shows Potential for Treating Prosthetic Joint Infections
Mayo Clinic ∙ 07/23/2020 ∙ CTSA Program -
Conversation Game May Reduce Disparity in African Americans' End-of-Life Care
Penn State ∙ 07/23/2020 ∙ CTSA Program -
Early Empirical Study on COVID-19 Related Depression and Anxiety Gives Reason for Optimism
Vanderbilt University ∙ 07/22/2020 ∙ CTSA Program -
Experimental Coronavirus Vaccine Is Safe and Produces Immune Response
NIH Research Matters ∙ 07/21/2020 ∙ NCATS -
URMC Receives Another $24 Million to Translate Research Discoveries into Health Improvements
University of Rochester Medical Center ∙ 07/21/2020 ∙ CTSA Program -
More Lonely Deaths in Hospitals and Nursing Homes from COVID
ScienceBlog.com ∙ 07/19/2020 ∙ CTSA Program -
Cells May Tell if Arthritis Flare-ups Are Coming
Rice University ∙ 07/17/2020 ∙ CTSA Program -
UIC Awarded $22M for Translational Research from NIH
University of Illinois at Chicago ∙ 07/16/2020 ∙ CTSA Program -
Researchers Discover a New Type of Cells That May Predict Flares in Rheumatoid Arthritis
Hospital for Special Surgery ∙ 07/16/2020 ∙ CTSA Program
June 2020
-
Blood Test at COVID-19 Diagnosis Can Predict Disease Severity, Study Finds
University of Virginia ∙ 06/29/2020 ∙ CTSA Program -
Unexpected Spectrum of Mental Illnesses Found in Patients with Rare Genetic Disorder
UC Davis Health ∙ 06/24/2020 ∙ CTSA Program -
C-Path Launches CURE Drug Repurposing Collaboratory to Accelerate Identification of New Uses of Existing Drugs to Treat Infectious Diseases, Including COVID-19
Critical Path Institute ∙ 06/23/2020 ∙ NCATS -
Better Measure of 'Good Cholesterol' Can Gauge Heart Attack and Stroke Risk in Some Populations
The University of Texas Southwestern Medical Center ∙ 06/22/2020 ∙ CTSA Program -
OSU Helping to Drive National Institutes of Health Effort to Harness Analytics in COVID-19 Fight
Oregon State University ∙ 06/22/2020 ∙ CTSA Program -
The Rate We Acquire Genetic Mutations Could Help Predict Lifespan, Fertility
University of Utah Health ∙ 06/19/2020 ∙ NCATS -
Identifying New Drug Targets by Illuminating the Druggable Genome
Massachusetts Biotechnology Council ∙ 06/18/2020 ∙ IDG -
Alpacas Could Be the Secret Weapon Against COVID-19
University of Kentucky, Center for Clinical and Translational Science ∙ 06/18/2020 ∙ CTSA Program -
iTHRIV Announces Incoming 2020 Scholars Program Cohort
University of Virginia ∙ 06/17/2020 ∙ CTSA Program -
TransCelerate Broadens Access to Shared COVID-19 Trial Data
BioCentury, Inc. ∙ 06/17/2020 ∙ CTSA Program -
Gut Bacteria May Contribute to Abnormal Blood Vessel Formation
NIH Research Matters ∙ 06/16/2020 ∙ NCATS -
Intabio Launches Blaze™ System to Accelerate Biotherapeutic Development
Intabio, Inc. ∙ 06/16/2020 ∙ NCATS -
Oral Antibiotics Work, Shorten Hospital Stays for IV Drug Users with Infections
Washington University in St. Louis ∙ 06/16/2020 ∙ CTSA Program -
Stress-Management Strategies Can Boost Health Care Teams During Pandemic
Rice University ∙ 06/15/2020 ∙ CTSA Program -
NCATS Seeks to Create Hub for COVID-19 Data; Regeneron Reports Preclinical Data Backing Antiviral mAb Cocktail
BioCentury, Inc. ∙ 06/15/2020 ∙ CTSA Program -
Disrupted Circadian Rhythms Linked to Later Parkinson's Diagnosis
University of California, San Francisco ∙ 06/15/2020 ∙ CTSA Program -
Disrupted Circadian Rhythms Linked to Later Parkinson's Diagnosis: Researchers Probe Brain’s 24-Hour Biological Clock for Neurodegenerative Risks
University of California, San Francisco ∙ 06/15/2020 ∙ CTSA Program -
Patients with COVID-19 Donate Specimens to Advance Research Efforts
Washington University in St. Louis ∙ 06/11/2020 ∙ CTSA Program -
FDA’s CURE ID App Gets a COVID-19 Refresh
Regulatory Affairs Professionals Society ∙ 06/10/2020 ∙ NCATS -
Clinical Trial Looks at Antiseptic Nasal Spray and Gargle to Prevent COVID-19 Infections
University of Kentucky, Center for Clinical and Translational Science ∙ 06/10/2020 ∙ CTSA Program -
Pilot Program for COVID-19 Research Launches Multiple Projects in Record Time
University of Kentucky, Center for Clinical and Translational Science ∙ 06/09/2020 ∙ CTSA Program -
NIH-Funded UNC Study Maps COVID-19 Infection in Nasal Cavity, Airway, Lungs
Federal Laboratory Consortium for Technology Transfer ∙ 06/09/2020 ∙ NCATS -
COVID-19 Rate Low among Pregnant Women, Study Finds
University of Washington ∙ 06/08/2020 ∙ CTSA Program -
Researchers Design Clinical Trial on Use of Exercise for Severe Liver Disease
ScienceBlog.com ∙ 06/08/2020 ∙ CTSA Program -
CURE ID App Lets Clinicians Report Novel Uses of Existing Drugs
Food and Drug Administration ∙ 06/08/2020 ∙ NCATS -
Researchers Design Clinical Trial on Use of Exercise for Severe Liver Disease
Penn State ∙ 06/05/2020 ∙ CTSA Program -
NCATS Director Discusses Center's Data-focused Approach to COVID-19
Federal Laboratory Consortium for Technology Transfer ∙ 06/03/2020 ∙ RDCRN -
Translational Research Hub at BU Gets $38.3 Million Renewal from NIH
Boston University School of Public Health ∙ 06/03/2020 ∙ CTSA Program -
Hesperos Demonstrates Innovative Human-on-a-Chip® Approach to Modeling Innate Immune System Response Following Tissue Damage and Acute Inflammation
Hesperos, Inc. ∙ 06/02/2020 ∙ SBIR/STIR, Tissue Chip -
Lab-Grown Miniature Human Livers Transplanted into Rats
University of Pittsburgh Medical Center ∙ 06/02/2020 ∙ Tissue Chip -
Expression of Certain Genes May Affect Vulnerability to Post-Traumatic Stress Disorder
McLean Hospital ∙ 06/02/2020 ∙ CTSA Program -
Pharmaceutical Testing Technology Developed at UCF for Immune Response Shows Promise for Multi-Organ Diseases
University of Central Florida ∙ 06/02/2020 ∙ SBIR/STIR -
Hesperos Demonstrates Innovative Human-On-A-Chip® Approach to Modeling Innate Immune System Response Following Tissue Damage and Acute Inflammation
Hesperos Inc. ∙ 06/02/2020 ∙ Tissue Chip -
Does Estrogen Influence Alcohol Use Disorder?
University of Illinois at Chicago ∙ 06/01/2020 ∙ CTSA Program -
Abstract 19: Targeting Delta133p53 Isoform with Small-Molecule Compounds to Modulate Cellular Senescence
American Association for Cancer Research ∙ 06/01/2020 ∙ NCGC
May 2020
-
Nilotinib Appears Safe and Affects Biomarkers in Alzheimer’s Disease Clinical Trial
Georgetown University Medical Center ∙ 05/29/2020 ∙ CTSA Program -
Cancer Therapeutics Start-up Has Roots in NCATS Research Collaboration
Federal Laboratory Consortium for Technology Transfer ∙ 05/29/2020 ∙ NCATS -
FDA Seeks Input on Rare Disease Clinical Trials Network
Regulatory Affairs Professionals Society ∙ 05/29/2020 ∙ RDCRN -
Top Chicago Universities Launch Social Movement to Team Up the Public & Researchers in Fight Against COVID-19 & Other Diseases
The University of Chicago Medical Center ∙ 05/28/2020 ∙ CTSA Program -
Mayo Researchers, Minority Communities Team Up to Combat COVID-19 Health Disparities
Mayo Clinic ∙ 05/28/2020 ∙ CTSA Program -
UChicago Partners on Effort to Pair Public with Researchers in Fight against COVID-19
University of Chicago ∙ 05/28/2020 ∙ CTSA Program -
Johns Hopkins, Stony Brook & 13 More Institutions Join NIH Collaborative to Build EHR Database for COVID-19 Research
Becker's Hospital Review ∙ 05/28/2020 ∙ CTSA Program -
Emory Researchers Report Lower ICU and Ventilator Mortality in Critically Ill Adults with COVID-19
Emory University, Woodruff Health Sciences Center ∙ 05/27/2020 ∙ CTSA Program -
A Simple and Readily Available Saline Solution Can Reliably Transport COVID-19 Samples to Testing Labs
Elsevier ∙ 05/27/2020 ∙ CTSA Program -
International gnomAD Consortium Releases Its First Major Studies of Human Genetic Variation
Broad Institute ∙ 05/27/2020 ∙ NCATS -
Gathering Big Data to Accelerate COVID-19 Fight
University of North Carolina at Chapel Hill School of Medicine ∙ 05/26/2020 ∙ CTSA Program -
Gathering Big Data to Accelerate the COVID-19 Fight
Oregon Health & Science University ∙ 05/26/2020 ∙ CTSA Program -
Bringing Brigatinib to Neurofibromatosis Type-2 Patients: From Promising Potential to Platform Clinical Trial
Children’s Tumor Foundation ∙ 05/26/2020 ∙ NCATS -
New Testing System Predicts Septic Shock Outcomes
The University of Chicago, Pritzker School of Molecular Engineering ∙ 05/26/2020 ∙ CTSA Program -
UK Neurologist Believes MS Diagnosis Guidelines Need Updated
University of Kentucky, Center for Clinical and Translational Science ∙ 05/23/2020 ∙ CTSA Program -
Translational Research Hub at BU Gets $38.3 Million Renewal from NIH
Boston University ∙ 05/21/2020 ∙ CTSA Program -
Ototoxicity of FDA-Approved Drugs Being Re-Purposed for COVID-19 Treatment
American Academy of Audiology ∙ 05/20/2020 ∙ NCATS -
Apps Help COVID Anxiety, Depression
Northwestern University ∙ 05/20/2020 ∙ CTSA Program -
The Lancet: First Prospective Study of Critically Ill COVID-19 Patients from New York City Sheds Light on How Virus Affects Adult Patients in USA
EurekAlert! ∙ 05/19/2020 ∙ CTSA Program -
Good News for Menopausal Women Taking Hop Supplements: Tests Show No Drug Interactions
Oregon State University ∙ 05/15/2020 ∙ CTSA Program -
Testing for Blood Clotting Abnormalities Reveals which Critically Ill COVID-19 Patients Are at Risk for Thrombotic Events and Need Hemodialysis
American College of Surgeons ∙ 05/15/2020 ∙ CTSA Program -
Determining Aspirin’s Benefit for Cardiovascular Disease Prevention
Northwestern University Feinberg School of Medicine ∙ 05/15/2020 ∙ CTSA Program -
Community Grant Recipient Uses Personal Health Journey to Help Others Prevent Diabetes
University of Kentucky, Center for Clinical and Translational Science ∙ 05/14/2020 ∙ CTSA Program -
Acer Therapeutics to Develop Emetine as Potential COVID-19 Treatment in Collaboration with National Center for Advancing Translational Sciences, One of the National Institutes of Health
Acer Therapeutics Inc. ∙ 05/11/2020 ∙ NCATS -
Survey to Explore COVID-19 Impact on Rare Diseases Community
Global Genes ∙ 05/11/2020 ∙ RDCRN -
Acer Therapeutics to Develop Emetine as Potential COVID-19 Treatment in Collaboration with National Center for Advancing Translational Sciences, One of the National Institutes of Health
Drugs.com ∙ 05/11/2020 ∙ NCATS -
Rare Diseases Clinical Research Network Opens Online Survey on COVID-19
Muscular Dystrophy News ∙ 05/11/2020 ∙ RDCRN -
UK Researchers Will Lead Study of COVID-19 Immunity
University of Kentucky ∙ 05/11/2020 ∙ CTSA Program -
Children’s Tumor Foundation Announces New NF2 Clinical Trial: INTUITT for NF2
Children's Tumor Foundation ∙ 05/08/2020 ∙ NCATS -
Artificial Intelligence Jump Starts Clinical Trial for Rare Genetic Disease
The University of Alabama at Birmingham ∙ 05/07/2020 ∙ Rare Diseases -
Racing Against Time: UNM Scientists Studying Ways to Repurpose Older Drugs to Treat COVID-19 Infection
The University of New Mexico ∙ 05/07/2020 ∙ CTSA Program -
COVID-19 Trial Finder Provides Simplified Search Process for COVID-Related Clinical Trials
Columbia University, Department of Biomedical Informatics ∙ 05/07/2020 ∙ CTSA Program -
Teen Obesity, Diabetes or High Blood Pressure May Lead to Prematurely Aged Arteries
American Heart Association, Inc. ∙ 05/06/2020 ∙ NCATS -
Tufts CTSI Announces Covid-19 Pilot Studies Grant Recipients
Tufts Clinical and Translational Science Institute ∙ 05/05/2020 ∙ CTSA Program -
$55M NIH Grant Advances Clinical and Translational Research at UC San Diego
University of California, San Diego ∙ 05/04/2020 ∙ CTSA Program -
Rare Disease Day and the DADA2 Story: It Takes Detective Work to Diagnose Rare Diseases
The NIH Catalyst ∙ 05/01/2020 ∙ Rare Diseases -
Ison, Misharin Receive COVID-19 Rapid Response Grants
Northwestern University Clinical and Translational Sciences Institute and Feinberg School of Medicine ∙ 05/01/2020 ∙ CTSA Program
April 2020
-
Kurome Therapeutics to Develop Therapies Targeting Cancer's Ability to Evade Treatment
Kurome Therapeutics ∙ 04/29/2020 ∙ Chemistry Technology, NCATS -
At NIH, Christopher Austin ’82 ‘Translates’ Science into Treatment for COVID-19
Princeton Alumni Weekly ∙ 04/29/2020 ∙ NCATS -
Diffusion Pharmaceuticals Announces Pre-IND Submission to the FDA of Design for TSC Trials to Treat Acute Respiratory Distress Syndrome in COVID-19
Diffusion Pharmaceuticals Inc. ∙ 04/27/2020 ∙ CTSA Program -
Noninvasive Test May Help Some Patients with Melanoma Avoid Lymph Node Biopsy
Mayo Clinic ∙ 04/27/2020 ∙ CTSA Program -
Stanford Chemists’ Work on Rare Molecule Aims to Enhance Cell Therapy and Deliver Functional Cure for HIV/AIDS
Stanford University ∙ 04/27/2020 ∙ NCATS -
Clinical Research in the Time of the COVID-19 Pandemic
Medical University of South Carolina ∙ 04/24/2020 ∙ CTSA Program -
Could Suicide Risk Be Predicted from a Patient's Records?
Medical Xpress ∙ 04/24/2020 ∙ CTSA Program -
Diabetes Reversed in Mice with Genetically Edited Stem Cells Derived from Patients
Washington University School of Medicine in St. Louis ∙ 04/22/2020 ∙ CTSA Program -
NCATS Funds Facilitate Development of Finger-Stick COVID-19 Test
Federal Laboratory Consortium for Technology Transfer ∙ 04/22/2020 ∙ CTSA Program -
NCATS Funding Use of Tissue Chips to Support COVID-19 Research
ALTEX - Alternatives to Animal Experimentation ∙ 04/22/2020 ∙ Tissue Chip -
Behavioral Intervention, Not Lovastatin, Improves Language Skills in Youth with Fragile X
UC Davis Health ∙ 04/22/2020 ∙ CTSA Program -
Study Explores How Memory Influences Visual Exploration
Northwestern University Feinberg School of Medicine ∙ 04/21/2020 ∙ CTSA Program -
Rutgers University Launches the Nation’s Largest Study of Health Care Workers Exposed to COVID-19
Rutgers, The State University of New Jersey ∙ 04/21/2020 ∙ CTSA Program -
Rare Disease Research Progressing, But Could Go Even Faster
NIH Record ∙ 04/17/2020 ∙ Rare Diseases -
Penn State Health Hospitals Now Using Plasma from Recovered Patients as Possible Treatment for COVID-19
Penn State College of Medicine ∙ 04/17/2020 ∙ CTSA Program -
Kebotix Raises $11.4 Million in Series A Funding for Rapid Discovery of Chemicals, Materials to Address Global Challenges
Kebotix, Inc. ∙ 04/16/2020 ∙ NCATS -
Researchers Get Important Glimpse Into Microbiome Development in Early Life
The Children’s Hospital of Philadelphia ∙ 04/16/2020 ∙ CTSA Program -
New COVID-19 Biobank at UK Will Support Research
University of Kentucky, Center for Clinical and Translational Science ∙ 04/16/2020 ∙ CTSA Program -
CWRU MD-PhD Student and CTSC TL1 Scholar Uriel Kim Wins Prestigious Clinical and Translational Science Award
Case Western Reserve University School of Medicine ∙ 04/15/2020 ∙ CTSA Program -
$765,789 Grant to Focus on Racial, Ethnic Health Disparities
University of Arkansas for Medical Sciences ∙ 04/14/2020 ∙ CTSA Program -
A Live View of Brain Tumor Growth: Mouse Study Shows How Advancing Glioma Cells Scramble Brain Function, Blood Flow
The Zuckerman Institute, Columbia University ∙ 04/14/2020 ∙ CTSA Program -
Clinical Trial Launches to Evaluate Antimalarial Drugs for COVID-19 Treatment
Washington University School of Medicine ∙ 04/09/2020 ∙ CTSA Program -
Three New KL2 Scholars Selected for 2020
University of Wisconsin-Madison, Institute for Clinical and Translational Research ∙ 04/09/2020 ∙ CTSA Program -
Stanford Researchers Devise Treatment that Relieved Depression in 90% of Participants in Small Study
Stanford Medicine ∙ 04/06/2020 ∙ CTSA Program -
The Heartbeats from Space: Heart Tissues Returned to UW Researchers after a Month at the International Space Station
University of Washington, Seattle ∙ 04/06/2020 ∙ Tissue Chip -
New Treatment for Childhood Anxiety Works by Changing Parent Behavior
Elsevier ∙ 04/02/2020 ∙ CTSA Program
March 2020
-
Getting Closer to a Blood Test for Alzheimer’s Disease?
NIH Director’s Blog ∙ 03/31/2020 ∙ RDCRN -
SCTR Institute Awarded $24 Million to Advance Translational Research in South Carolina
Medical University of South Carolina ∙ 03/30/2020 ∙ CTSA Program -
Developing Better Kidney Disease Models in Microgravity
ISS U.S. National Laboratory ∙ 03/30/2020 ∙ Tissue Chip -
Third Coronavirus Response Bill Includes Research Boost
American Institute of Physics ∙ 03/27/2020 ∙ NCATS -
Congress Passes COVID-19 Stimulus Bill – Includes Science Funding
The American Society for Cell Biology ∙ 03/27/2020 ∙ NCATS -
Astronaut Conducts Heart Research on Station with Former Colleague
National Aeronautics and Space Administration ∙ 03/25/2020 ∙ Tissue Chip -
At the Heart of Spaceflight
ISS U.S. National Laboratory ∙ 03/25/2020 ∙ Tissue Chip -
Five Language Outcome Measures Evaluated for Intellectual Disabilities Studies
UC Davis Health ∙ 03/24/2020 ∙ CTSA Program -
C-Path Receives FDA Grant to Establish Rare Disease Clinical Outcome Assessment Consortium
Arizona Bioindustry Association ∙ 03/19/2020 ∙ Rare Diseases -
E-Cigarette Users Had Substances Linked to Bladder Cancer in Urine, Review Finds
UNC Lineberger Comprehensive Cancer Center ∙ 03/19/2020 ∙ CTSA Program -
Having a Low Birthweight Baby May Increase Risk for Early Heart Failure
American College of Cardiology ∙ 03/18/2020 ∙ NCATS -
Two-Step Method Patches Herniated Discs
Cornell University ∙ 03/11/2020 ∙ CTSA Program -
Irregular Sleep Patterns May Raise Risk of Heart Disease
NIH Research Matters ∙ 03/10/2020 ∙ NIH -
Blood Platelets Trigger Events that Cause Organ Damage After Heart Surgery
Duke University Health System ∙ 03/09/2020 ∙ CTSA Program -
Cancerous Tumors, Surrounding Cells Illuminated by New Imaging Agent
Washington University School of Medicine ∙ 03/09/2020 ∙ CTSA Program -
Arming the Body’s Immune Cells
University of Cincinnati ∙ 03/09/2020 ∙ CTSA Program -
New Paper Describes Accurate, Scalable Method for Detecting Fragile X Syndrome in Newborns
RTI International ∙ 03/05/2020 ∙ CTSA Program -
Device Helps Deliver Electronic Cigarette Vapors for Research
Penn State ∙ 03/04/2020 ∙ CTSA Program -
People with MS Are Living Longer. How Does Neurodegeneration in These Patients Change as They Age?
University at Buffalo ∙ 03/04/2020 ∙ CTSA Program -
Little Tissue, Big Mission: Beating Heart Tissues to Ride Aboard The ISS
Johns Hopkins University ∙ 03/04/2020 ∙ Tissue Chip -
Newfound Cell Defense System Features Toxin-Isolating ‘Sponges’
NYU Langone Health ∙ 03/04/2020 ∙ CTSA Program -
Memory Concerns? Blood Test May Put Mind at Ease or Pave Way to Promising Treatments
University of California, San Francisco ∙ 03/02/2020 ∙ RDCRN -
Despite Best Intentions, Researchers Don’t Always Share Findings with Study Participants
Medical University of South Carolina ∙ 03/02/2020 ∙ CTSA Program
February 2020
-
Seven Questions for a Rare Disease Warrior
NIH Director’s Blog ∙ 02/27/2020 ∙ Rare Diseases -
Mortality Decreased among People with Opioid Use Disorder who Receive Further Treatment After Detox
Boston Medical Center ∙ 02/25/2020 ∙ CTSA Program -
BioUtah and the University of Utah’s TVC Announce Startups Chosen to Pitch at the 2020 Entrepreneur & Investor Life Science Summit
BioUtah ∙ 02/24/2020 ∙ NCATS, SBIR/STIR -
Diabetes in Mice Cured Rapidly Using Human Stem Cell Strategy
Washington University School of Medicine ∙ 02/24/2020 ∙ CTSA Program -
Media Advisory: NIH-Funded Effort May Help People with Intellectual Disability Participate in Clinical Studies
NCATS, NICHD ∙ 02/24/2020 ∙ CTSA Program -
A Cancerous Conversation Fuels Oral Tumors
NCATS, NIDCR ∙ 02/18/2020 ∙ ExRNA -
Activity Tracker Data May Help Improve Flu-like Outbreak Predictions
NIH Office of Behavioral and Social Sciences Research ∙ 02/18/2020 ∙ CTSA Program -
Kebotix, NCATS Collaborate to Deliver New Treatments for Diseases Faster
Kebotix, Inc. ∙ 02/12/2020 ∙ NCATS -
Novel Melatonin Receptor Molecules Make Possible Therapies That Adjust Biological Clocks to Our Environments
University at Buffalo ∙ 02/10/2020 ∙ CTSA Program -
U-M Team Targets Muscular Dystrophy in Mice
University of Michigan ∙ 02/07/2020 ∙ Rare Diseases -
NIH Holds Inaugural Seminar on American Rural Health
NIH Record ∙ 02/07/2020 ∙ CTSA Program
January 2020
-
BPA Exposure in Pregnancy Affects Genes Related to Obesity and Diabetes
The Children’s Hospital of Philadelphia ∙ 01/28/2020 ∙ CTSA Program -
Genetic Testing in Diverse Young Breast Cancer Patients over a Decade
Florida Atlantic University ∙ 01/28/2020 ∙ CTSA Program -
Micro-Scaled Method Holds Promise for Cancer Diagnosis
Baylor College of Medicine ∙ 01/27/2020 ∙ CTSA Program -
Teens with Obesity and PCOS Have More "Unhealthy" Bacteria
Endocrine Society ∙ 01/23/2020 ∙ CTSA Program -
Study Examines Reliability of Biopsies from Donated Kidneys Prior to Transplantation
American Society of Nephrology ∙ 01/23/2020 ∙ CTSA Program -
Adrenaline Handbrake
Harvard Medical School ∙ 01/22/2020 ∙ CTSA Program -
Study Finds Link between Blood Fats, Artery Size in MS Patients
University at Buffalo ∙ 01/22/2020 ∙ CTSA Program -
Insurance Status Helps Explain Racial Disparities in Cancer Diagnosis
NIH Director’s Blog ∙ 01/21/2020 ∙ CTSA Program -
Changing Cancer Care, One Organoid at a Time
Wake Forest Baptist Medical Center ∙ 01/21/2020 ∙ CTSA Program -
Statewide Autism Study Finds Later Diagnoses for Girls, High Rates of Co-Occurring Disorders
Brown University ∙ 01/20/2020 ∙ CTSA Program -
Walnuts May Be Good for the Gut and Help Promote Heart Health
Penn State ∙ 01/16/2020 ∙ CTSA Program -
Study Challenges Concerns over Hospital Readmission Reduction Practices
The University of Texas Southwestern Medical Center ∙ 01/15/2020 ∙ CTSA Program -
Study Finds Novel Molecular Therapeutic Target for Colon Cancer
Boston University School of Medicine ∙ 01/14/2020 ∙ CTSA Program -
Racial Disparities in Heart Failure Explained
The University of Texas Southwestern Medical Center ∙ 01/14/2020 ∙ CTSA Program -
Are Racial/Ethnic Disparities in Breast Cancer Diagnosis Caused by Health Insurance Coverage?
The ASCO Post ∙ 01/14/2020 ∙ CTSA Program -
Researchers Find Clues to Drug Resistance in Medulloblastoma Subtype
University of North Carolina at Chapel Hill School of Medicine ∙ 01/13/2020 ∙ CTSA Program -
New Tests May Help Diagnose Rare Subset of Eosinophilic Disorders
Cincinnati Children's Hospital Medical Center ∙ 01/06/2020 ∙ RDCRN -
Center for Health Equity Transformation Seeks to Improve Health of All Kentuckians
University of Kentucky, Center for Clinical and Translational Science ∙ 01/02/2020 ∙ CTSA Program -
Duke Researchers Garner Over $6 Million in NIH Funding to Fight Genetic Diseases
Duke University, Pratt School of Engineering ∙ 01/02/2020 ∙ Somatic Cell Genome Editing
-
Mayo Clinic Launches COVID-19 Research Vaccine Registry to Identify People Interested in Participating in Future Clinical Trials
-